The Seattle Seahawks, Super Bowl Winners, Go Up for Sale

Key takeaways

The sale of the Seattle Seahawks could potentially break NFL sales records.
Mark Zuckerberg's testimony reaffirms Meta's position on not targeting child users despite claims of social media's addictiveness.
Moderna's flu shot review by the FDA highlights the evolving landscape of vaccine technology.
US-Taiwan arms deal is complicated by geopolitical tensions with China, impacting diplomatic relations.
UnitedHealth Group's investment practices under Stephen Hemsley are causing concerns about conflicts of interest.

Summary

Seattle Seahawks Sale

The Seattle Seahawks, winners of the Super Bowl, are now officially up for sale following the passing of their owner, Paul Allen, in 2018. The NFL is pushing for the sale to comply with league rules due to the unusual trust structure in place. Observers predict that the sale could fetch a record price of over $6 billion.

Zuckerberg Testifies at Landmark Trial

In a significant legal moment, Meta's CEO Mark Zuckerberg testified at a high-stakes trial where social media companies are being challenged for their addictiveness, specifically towards teens. He defended Meta's growth objectives, asserting they focus on providing value rather than creating addiction, while denying efforts to target children.

Moderna's Flu Shot Review

The FDA's decision to review Moderna's new seasonal flu shot marks a turnaround from its earlier stance. The vaccine utilizes messenger RNA technology, similar to the COVID-19 vaccine. Discussion highlighted concerns raised regarding its efficacy for older adults compared to high-dose flu vaccines.

US-Taiwan Arms Deal Uncertainty

The prospects of a planned US arms deal with Taiwan are currently in jeopardy as the Trump administration weighs the pressure from China regarding the deal and its implications for the upcoming Beijing summit.

UnitedHealth Investments Under Scrutiny

Stephen Hemsley, leader of UnitedHealth Group, faced scrutiny for private investments in competing healthcare startups while leading UnitedHealth. Although he claims to comply with conflict of interest policies, concerns regarding transparency and ethical considerations remain.

Show notes

P.M. Edition for Feb. 18. A long-anticipated sale of the Seattle Seahawks is now underway—and the sale price could break NFL records. Plus, Stephen Hemsley, the leader of UnitedHealth Group, for years made private investments in healthcare startups. Journal senior editor Mark Maremont digs into how some of those companies also did business with, or competed against, UnitedHealth. And in his testimony at a landmark social media trial, Meta CEO Mark Zuckerberg defended the company’s practices. Alex Ossola hosts.

Sign up for the WSJ's free What's News newsletter.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.